K. Nozaki

发表

Synthetic biodegradable polymers as drug delivery systems for bone morphogenetic proteins.

K. Takaoka, N. Murakami, H. Horiuchi, 2005, Advanced drug delivery reviews.

New Synthetic Biodegradable Polymers for Bone Morphogenetic Protein Delivery Systems

K. Takaoka, N. Murakami, H. Horiuchi, 2003 .

Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers.

K. Takaoka, N. Murakami, H. Horiuchi, 2003, Bone.

Biodegradable Poly-d,l-Lactic Acid-Polyethylene Glycol Block Copolymers as a BMP Delivery System for Inducing Bone

K. Takaoka, N. Murakami, H. Horiuchi, 2001, The Journal of bone and joint surgery. American volume.

Comparison of incadronate and alfacalcidol on increased bone turnover caused by ovariectomy in rats.

Koichiro Takahashi, K. Nozaki, S. Kokubo, 2002, European journal of pharmacology.

Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model.

M. Sasamata, K. Nozaki, K. Miyata, 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model.

Koichiro Takahashi, K. Nozaki, K. Miyata, 2003, Biomaterials.

Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier.

K. Takaoka, N. Murakami, H. Horiuchi, 2003, Biomaterials.

Recombinant Human Bone Morphogenetic Protein-2 as an Osteoinductive Biomaterial and a Biodegradable Carrier in a Rabbit Ulnar Defect Model

Koichiro Takahashi, K. Nozaki, K. Miyata, 2008 .

Release of recombinant human bone morphogenetic protein 2 from a newly developed carrier.

T. Uchida, T. Sonobe, K. Nozaki, 2003, International journal of pharmaceutics.

Effect of incadronate on corticosteroid-induced osteopenia in rats.

Koichiro Takahashi, K. Nozaki, K. Miyata, 2004, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Repair of segmental defects in rabbit humeri with titanium fiber mesh cylinders containing recombinant human bone morphogenetic protein-2 (rhBMP-2) and a synthetic polymer.

K. Takaoka, N. Murakami, H. Horiuchi, 2002, Journal of biomedical materials research.

Anterior Thoracic Spinal Fusion in Dogs by Injection of Recombinant Human Bone Morphogenetic Protein-2 and a Synthetic Polymer

K. Takaoka, S. Ebara, H. Itoh, 2003, Journal of spinal disorders & techniques.

Long-term stability of bone tissues induced by an osteoinductive biomaterial, recombinant human bone morphogenetic protein-2 and a biodegradable carrier.

M. Mochizuki, N. Sasaki, Teruo Itô, 2004, Biomaterials.

A biodegradable polymer as a cytokine delivery system for inducing bone formation

Kazutoshi Nozaki, Naoto Saito, Takao Okada, 2001, Nature Biotechnology.

Accelerated repair of a bone defect with a synthetic biodegradable bone-inducing implant

H. Terai, K. Takaoka, S. Miyamoto, 2006, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

A new bone‐inducing biodegradable porous β‐tricalcium phosphate

Kazutoshi Nozaki, Takao Okada, H. Terai, 2004 .

Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant.

Masahiro Yoneda, Kazutoshi Nozaki, Yuuki Imai, 2005, Biomaterials.

A new recombinant human bone morphogenetic protein-2 carrier for bone regeneration.

T. Uchida, M. Murai, T. Sonobe, 2001, International journal of pharmaceutics.

A new bone-inducing biodegradable porous beta-tricalcium phosphate.

H. Terai, K. Takaoka, S. Miyamoto, 2004, Journal of biomedical materials research. Part A.

The effects of heat on the biological activity of recombinant human bone morphogenetic protein-2

Yuuki Imai, K. Takaoka, Yukio Nakamura, 2005, Journal of Bone and Mineral Metabolism.

Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.

Y. Yamagami, Tetsuji Yamamoto, T. Mashiba, 2013, Bone.

Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.

Toshitaka Nakamura, K. Nozaki, Makoto Tanaka, 2013, Bone.

Incadronate inhibits osteoporosis in ovariectomized rats.

Kazutoshi Nozaki, Koichiro Takahashi, K. Nozaki, 2002, European journal of pharmacology.

Diagnosis Patterns of CKD and Anemia in the Japanese Population

Tomomi Kimura, K. Nozaki, R. Snijder, 2020, Kidney international reports.

Enzymologic and pharmacologic profile of loxoprofen sodium and its metabolites.

J. Gierse, M. Sasamata, B. Zweifel, 2005, Biological & pharmaceutical bulletin.